| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.735 | 0.009 | 0.735 | Antiobesity | 0.318 0.104 DBMET00909 | ||
| 0.594 | 0.002 | 0.594 | Mineralocorticoid receptor antagonist | |||
| 0.603 | 0.027 | 0.603 | Cyclophilin D inhibitor | 0.264 0.197 DBMET00909 | ||
| 0.557 | 0.002 | 0.557 | CYP2A6 inhibitor | 0.183 0.01 DBMET00909 | ||
| 0.566 | 0.012 | 0.566 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.525 0.023 DBMET00909 | ||
| 0.537 | 0.003 | 0.537 | Gonadotropin-releasing hormone receptor antagonist | 0.147 0.005 DBMET00909 | ||
| 0.501 | 0.004 | 0.501 | Aldehyde dehydrogenase inhibitor | 0.15 0.047 DBMET00909 | ||
| 0.489 | 0.004 | 0.489 | Hedgehog signaling inhibitor | 0.21 0.01 DBMET00909 | ||
| 0.484 | 0.03 | 0.484 | GABA C receptor rho-3 antagonist | 0.368 0.076 DBMET00909 | ||
| 0.423 | 0.007 | 0.423 | Protein-tyrosine phosphatase inhibitor | |||
| 0.408 | 0.005 | 0.408 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.421 | 0.023 | 0.421 | Superoxide dismutase inhibitor | 0.302 0.05 DBMET00909 | ||
| 0.437 | 0.057 | 0.462 | 5 Hydroxytryptamine release inhibitor | 0.462 0.046 DBMET00909 | DBMET00909 | |
| 0.387 | 0.052 | 0.515 | Cholesterol antagonist | 0.515 0.03 DBMET00909 | DBMET00909 | |
| 0.396 | 0.078 | 0.437 | Histamine release inhibitor | 0.437 0.056 DBMET00909 | DBMET00909 | |
| 0.324 | 0.007 | 0.35 | Nitric-oxide synthase stimulant | 0.35 0.005 DBMET00909 | DBMET00909 | |
| 0.314 | 0.004 | 0.314 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.319 | 0.019 | 0.319 | Diuretic | |||
| 0.301 | 0.044 | 0.301 | 5 Hydroxytryptamine uptake stimulant | 0.238 0.094 DBMET00909 | ||
| 0.287 | 0.04 | 0.461 | Peroxidase inhibitor | 0.461 0.013 DBMET00909 | DBMET00909 | |
| 0.371 | 0.129 | 0.371 | Caspase 9 stimulant | 0.363 0.136 DBMET00909 | ||
| 0.231 | 0.009 | 0.231 | Porphobilinogen synthase inhibitor | 0.208 0.011 DBMET00909 | ||
| 0.243 | 0.039 | 0.243 | MAP kinase kinase 3 inhibitor | 0.225 0.065 DBMET00909 | ||
| 0.242 | 0.043 | 0.242 | Neurotrophic factor enhancer | 0.235 0.048 DBMET00909 | ||
| 0.186 | 0.004 | 0.186 | Aldosterone antagonist | |||
| 0.22 | 0.041 | 0.22 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.28 | 0.107 | 0.418 | Vasodilator, peripheral | 0.418 0.05 DBMET00909 | DBMET00909 | |
| 0.171 | 0.008 | 0.171 | Acetylcholine release stimulant | 0.143 0.021 DBMET00909 | ||
| 0.201 | 0.04 | 0.201 | Interferon gamma antagonist | 0.178 0.051 DBMET00909 | ||
| 0.197 | 0.036 | 0.197 | Arachidonic acid antagonist | 0.185 0.048 DBMET00909 | ||
| 0.273 | 0.12 | 0.317 | Calcium channel activator | 0.317 0.075 DBMET00909 | DBMET00909 | |
| 0.174 | 0.029 | 0.313 | Ferrochelatase inhibitor | 0.313 0.006 DBMET00909 | DBMET00909 | |
| 0.182 | 0.04 | 0.182 | GABA C receptor rho-2 antagonist | 0.151 0.073 DBMET00909 | ||
| 0.23 | 0.09 | 0.274 | Aldehyde oxidase inhibitor | 0.274 0.074 DBMET00909 | DBMET00909 | |
| 0.243 | 0.111 | 0.243 | Ca(v)3.3 blocker | |||
| 0.172 | 0.044 | 0.237 | Alpha-N-acetylglucosaminidase inhibitor | 0.237 0.025 DBMET00909 | DBMET00909 | |
| 0.172 | 0.047 | 0.172 | Cytokine production inhibitor | |||
| 0.153 | 0.028 | 0.153 | Protease inhibitor | |||
| 0.22 | 0.104 | 0.22 | Tyrosine 3 hydroxylase inhibitor | 0.18 0.177 DBMET00909 | ||
| 0.151 | 0.038 | 0.151 | Death-associated protein kinase 1 inhibitor | |||
| 0.18 | 0.068 | 0.18 | Succinate dehydrogenase inhibitor | 0.166 0.086 DBMET00909 | ||
| 0.219 | 0.107 | 0.219 | 5 Hydroxytryptamine release stimulant | 0.209 0.114 DBMET00909 | ||
| 0.188 | 0.081 | 0.199 | Anesthetic general | 0.199 0.075 DBMET00909 | DBMET00909 | |
| 0.202 | 0.096 | 0.202 | RNA-directed DNA polymerase inhibitor | 0.2 0.1 DBMET00909 | ||
| 0.149 | 0.045 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.155 0.032 DBMET00909 | DBMET00909 | |
| 0.146 | 0.043 | 0.329 | Interleukin 1b antagonist | 0.329 0.007 DBMET00909 | DBMET00909 | |
| 0.158 | 0.058 | 0.158 | Mannose-6-phosphate isomerase inhibitor | 0.124 0.094 DBMET00909 | ||
| 0.137 | 0.038 | 0.139 | GABA C receptor antagonist | 0.139 0.037 DBMET00909 | DBMET00909 | |
| 0.121 | 0.03 | 0.195 | Lanosterol 14 alpha demethylase inhibitor | 0.195 0.005 DBMET00909 | DBMET00909 | |
| 0.185 | 0.093 | 0.185 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.111 | 0.02 | 0.111 | Epoxide hydrolase inhibitor | |||
| 0.106 | 0.017 | 0.132 | Alcohol oxidase inhibitor | 0.132 0.012 DBMET00909 | DBMET00909 | |
| 0.111 | 0.023 | 0.111 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.072 DBMET00909 | ||
| 0.111 | 0.023 | 0.111 | Nicotinic alpha4beta2 receptor antagonist | 0.088 0.042 DBMET00909 | ||
| 0.126 | 0.039 | 0.126 | UDP-glucose 4-epimerase inhibitor | 0.115 0.047 DBMET00909 | ||
| 0.136 | 0.05 | 0.136 | CC chemokine 6 receptor antagonist | 0.132 0.063 DBMET00909 | ||
| 0.09 | 0.007 | 0.09 | Glutamate (mGluR4) antagonist | |||
| 0.147 | 0.067 | 0.179 | Adenylate cyclase stimulant | 0.179 0.027 DBMET00909 | DBMET00909 | |
| 0.084 | 0.006 | 0.084 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.117 | 0.04 | 0.117 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.102 0.052 DBMET00909 | ||
| 0.124 | 0.047 | 0.125 | GABA C receptor agonist | 0.125 0.046 DBMET00909 | DBMET00909 | |
| 0.095 | 0.019 | 0.095 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.13 | 0.056 | 0.25 | Cholesterol synthesis inhibitor | 0.25 0.018 DBMET00909 | DBMET00909 | |
| 0.118 | 0.047 | 0.118 | DOPA decarboxylase inhibitor | 0.101 0.074 DBMET00909 | ||
| 0.102 | 0.032 | 0.102 | p38 MAP kinase inhibitor | |||
| 0.123 | 0.055 | 0.123 | TRPA1 agonist | |||
| 0.086 | 0.019 | 0.086 | Exportin-1 inhibitor | 0.082 0.023 DBMET00909 | ||
| 0.073 | 0.006 | 0.073 | Potassium channel Kv1.1 blocker | |||
| 0.14 | 0.074 | 0.177 | Pregnane X receptor agonist | 0.177 0.02 DBMET00909 | DBMET00909 | |
| 0.094 | 0.029 | 0.267 | Vanilloid 1 antagonist | 0.267 0.007 DBMET00909 | DBMET00909 | |
| 0.12 | 0.058 | 0.12 | Cystathionine beta-synthase inhibitor | 0.101 0.076 DBMET00909 | ||
| 0.145 | 0.084 | 0.145 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.076 | 0.015 | 0.087 | Aconitate hydratase inhibitor | 0.087 0.011 DBMET00909 | DBMET00909 | |
| 0.071 | 0.013 | 0.075 | Pregnane X receptor antagonist | 0.075 0.01 DBMET00909 | DBMET00909 | |
| 0.079 | 0.021 | 0.099 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.099 0.014 DBMET00909 | DBMET00909 | |
| 0.073 | 0.016 | 0.073 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.067 | 0.01 | 0.067 | Glutamate (mGluR group III) antagonist | |||
| 0.107 | 0.053 | 0.107 | GABA C receptor rho-1 antagonist | 0.104 0.056 DBMET00909 | ||
| 0.123 | 0.071 | 0.123 | Cathepsin H inhibitor | |||
| 0.149 | 0.101 | 0.149 | Tumour necrosis factor antagonist | |||
| 0.102 | 0.054 | 0.102 | Electrolyte absorption antagonist | 0.097 0.062 DBMET00909 | ||
| 0.089 | 0.042 | 0.089 | Glutamate (mGluR) antagonist | |||
| 0.083 | 0.035 | 0.083 | Glycine receptor agonist | 0.077 0.042 DBMET00909 | ||
| 0.078 | 0.03 | 0.078 | Glutamate (mGluR7) antagonist | 0.071 0.041 DBMET00909 | ||
| 0.127 | 0.08 | 0.276 | Interleukin 1 antagonist | 0.276 0.014 DBMET00909 | DBMET00909 | |
| 0.073 | 0.027 | 0.073 | Cathepsin B inhibitor | |||
| 0.079 | 0.037 | 0.079 | Neuronal nicotinic receptor antagonist | |||
| 0.084 | 0.043 | 0.094 | Keratolytic | 0.094 0.034 DBMET00909 | DBMET00909 | |
| 0.079 | 0.038 | 0.178 | Phenylalanine 4-hydroxylase inhibitor | 0.178 0.009 DBMET00909 | DBMET00909 | |
| 0.087 | 0.048 | 0.087 | Acetylcholine nicotinic antagonist | |||
| 0.087 | 0.048 | 0.087 | Estrogen-related receptor beta agonist | 0.083 0.058 DBMET00909 | ||
| 0.048 | 0.01 | 0.048 | Vanilloid 3 antagonist | 0.041 0.019 DBMET00909 | ||
| 0.057 | 0.019 | 0.057 | Dopamine beta hydroxylase inhibitor | 0.055 0.022 DBMET00909 | ||
| 0.091 | 0.054 | 0.112 | Ornithine decarboxylase inhibitor | 0.112 0.032 DBMET00909 | DBMET00909 | |
| 0.082 | 0.045 | 0.097 | Vanilloid antagonist | 0.097 0.037 DBMET00909 | DBMET00909 | |
| 0.054 | 0.019 | 0.055 | Geranyltranstransferase inhibitor | 0.055 0.017 DBMET00909 | DBMET00909 | |
| 0.095 | 0.059 | 0.102 | Toll-Like receptor 3 antagonist | 0.102 0.047 DBMET00909 | DBMET00909 | |
| 0.069 | 0.035 | 0.069 | Aromatase inhibitor | 0.069 0.035 DBMET00909 | ||
| 0.06 | 0.025 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.054 0.043 DBMET00909 | ||
| 0.066 | 0.034 | 0.066 | Histone deacetylase SIRT3 inhibitor | |||
| 0.1 | 0.068 | 0.122 | Adenylate kinase inhibitor | 0.122 0.042 DBMET00909 | DBMET00909 | |
| 0.135 | 0.104 | 0.135 | Heat shock protein 90 alpha antagonist | |||
| 0.059 | 0.028 | 0.06 | Thromboxane synthase inhibitor | 0.06 0.028 DBMET00909 | DBMET00909 | |
| 0.097 | 0.067 | 0.117 | Anabolic | 0.117 0.043 DBMET00909 | DBMET00909 | |
| 0.135 | 0.105 | 0.153 | Melanin inhibitor | 0.153 0.077 DBMET00909 | DBMET00909 | |
| 0.124 | 0.096 | 0.124 | Cytidine deaminase inhibitor | |||
| 0.048 | 0.02 | 0.048 | Nerve growth factor antagonist | 0.04 0.035 DBMET00909 | ||
| 0.058 | 0.031 | 0.058 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.069 | 0.042 | 0.069 | Potassium channel (ATP-sensitive) blocker | |||
| 0.075 | 0.049 | 0.075 | Nav1.8 sodium channel blocker | |||
| 0.09 | 0.065 | 0.098 | HIV-1 integrase (Overall Integration) inhibitor | 0.098 0.056 DBMET00909 | DBMET00909 | |
| 0.033 | 0.008 | 0.087 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.087 0.005 DBMET00909 | DBMET00909 | |
| 0.062 | 0.038 | 0.062 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.104 | 0.08 | 0.116 | Photosensitizer | 0.116 0.063 DBMET00909 | DBMET00909 | |
| 0.034 | 0.012 | 0.034 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.035 | 0.014 | 0.035 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.064 | 0.044 | 0.064 | Transcription factor RelA inhibitor | |||
| 0.024 | 0.005 | 0.024 | CC chemokine 9 receptor antagonist | 0.018 0.011 DBMET00909 | ||
| 0.233 | 0.214 | 0.233 | MAP kinase kinase 6 inhibitor | |||
| 0.071 | 0.052 | 0.083 | Aminopeptidase I inhibitor | 0.083 0.04 DBMET00909 | DBMET00909 | |
| 0.048 | 0.029 | 0.048 | Glutamate (mGluR5) agonist | |||
| 0.071 | 0.053 | 0.092 | Glutamate decarboxylase inhibitor | 0.092 0.034 DBMET00909 | DBMET00909 | |
| 0.05 | 0.034 | 0.05 | Squalene epoxidase inhibitor | |||
| 0.072 | 0.056 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.175 | 0.16 | 0.175 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.053 | 0.039 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.105 | 0.092 | 0.109 | Transcription factor STAT6 inhibitor | 0.109 0.083 DBMET00909 | DBMET00909 | |
| 0.057 | 0.044 | 0.074 | Biliverdin reductase inhibitor | 0.074 0.029 DBMET00909 | DBMET00909 | |
| 0.08 | 0.067 | 0.08 | Histamine N-methyltransferase inhibitor | |||
| 0.047 | 0.034 | 0.047 | Glutamate (mGluR group I) agonist | |||
| 0.185 | 0.172 | 0.185 | Gastrin inhibitor | |||
| 0.141 | 0.129 | 0.141 | Death-associated protein kinase 2 inhibitor | |||
| 0.037 | 0.026 | 0.037 | Factor XIIIa inhibitor | |||
| 0.065 | 0.054 | 0.065 | MDM2 inhibitor | |||
| 0.039 | 0.027 | 0.062 | Alpha 1d adrenoreceptor agonist | 0.062 0.01 DBMET00909 | DBMET00909 | |
| 0.053 | 0.042 | 0.053 | Bombesin 3 receptor antagonist | |||
| 0.053 | 0.043 | 0.053 | Argininosuccinate synthase inhibitor | |||
| 0.043 | 0.033 | 0.043 | Histamine H1 receptor agonist | |||
| 0.042 | 0.033 | 0.044 | Heme oxygenase inhibitor | 0.044 0.025 DBMET00909 | DBMET00909 | |
| 0.036 | 0.028 | 0.036 | Delayed rectifier potassium channel blocker | |||
| 0.081 | 0.073 | 0.102 | Triose-phosphate isomerase inhibitor | 0.102 0.045 DBMET00909 | DBMET00909 | |
| 0.039 | 0.031 | 0.039 | Glutamate (mGluR1a) antagonist | |||
| 0.126 | 0.118 | 0.126 | MAP kinase 3 inhibitor | |||
| 0.025 | 0.018 | 0.031 | Prostaglandin H2 antagonist | 0.031 0.012 DBMET00909 | DBMET00909 | |
| 0.067 | 0.061 | 0.067 | Phospholipase D inhibitor | |||
| 0.12 | 0.115 | 0.122 | NOS3 expression enhancer | 0.122 0.112 DBMET00909 | DBMET00909 | |
| 0.027 | 0.022 | 0.027 | Glucosylceramidase stimulant | |||
| 0.013 | 0.009 | 0.013 | Cyclin D2 inhibitor | |||
| 0.048 | 0.044 | 0.058 | Acyl-CoA dehydrogenase inhibitor | 0.058 0.034 DBMET00909 | DBMET00909 | |
| 0.015 | 0.013 | 0.015 | Nicotinic alpha4 receptor agonist | |||
| 0.045 | 0.044 | 0.045 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.006 | 0.005 | 0.006 | CC chemokine 6 receptor agonist | |||
| 0.079 | 0.077 | 0.092 | NADH dehydrogenase inhibitor | 0.092 0.054 DBMET00909 | DBMET00909 | |
| 0.19 | 0.191 | 0.243 | Vasodilator, coronary | 0.243 0.141 DBMET00909 | DBMET00909 | |
| 0.038 | 0.039 | 0.04 | Kainate receptor agonist | 0.04 0.031 DBMET00909 | DBMET00909 | |
| 0.086 | 0.088 | 0.095 | Phosphodiesterase 6D inhibitor | 0.095 0.062 DBMET00909 | DBMET00909 | |
| 0.016 | 0.02 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DBMET00909 | DBMET00909 | |
| 0.168 | 0.172 | 0.21 | DNA synthesis inhibitor | 0.21 0.108 DBMET00909 | DBMET00909 | |
| 0.063 | 0.068 | 0.073 | Glutamate dehydrogenase inhibitor | 0.073 0.053 DBMET00909 | DBMET00909 | |
| 0.145 | 0.152 | 0.152 | Growth factor agonist | 0.152 0.137 DBMET00909 | DBMET00909 | |
| 0.05 | 0.057 | 0.056 | Botulinum neurotoxin type A inhibitor | 0.056 0.045 DBMET00909 | DBMET00909 | |
| 0.054 | 0.063 | 0.072 | Phosphofructokinase-1 inhibitor | 0.072 0.046 DBMET00909 | DBMET00909 | |
| 0.041 | 0.052 | 0.054 | Lysophosphatidic acid 3 receptor antagonist | 0.054 0.03 DBMET00909 | DBMET00909 | |
| 0.05 | 0.063 | 0.057 | Purinergic P2X1 antagonist | 0.057 0.049 DBMET00909 | DBMET00909 | |
| 0.078 | 0.091 | 0.107 | Sphingomyelinase inhibitor | 0.107 0.052 DBMET00909 | DBMET00909 | |
| 0.039 | 0.054 | 0.045 | Glucose-6-phosphate isomerase inhibitor | 0.045 0.04 DBMET00909 | DBMET00909 | |
| 0.054 | 0.073 | 0.081 | Catalase inhibitor | 0.081 0.047 DBMET00909 | DBMET00909 | |
| 0.043 | 0.068 | 0.055 | Carbamoyl phosphate synthetase inhibitor | 0.055 0.049 DBMET00909 | DBMET00909 | |
| 0.025 | 0.051 | 0.044 | Diamine oxidase inhibitor | 0.044 0.019 DBMET00909 | DBMET00909 | |
| 0.021 | 0.05 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET00909 | DBMET00909 | |
| 0.025 | 0.056 | 0.04 | Ceramide glucosyltransferase inhibitor | 0.04 0.018 DBMET00909 | DBMET00909 | |
| 0.05 | 0.084 | 0.079 | Na+ K+ transporting ATPase inhibitor | 0.079 0.052 DBMET00909 | DBMET00909 | |
| 0.098 | 0.142 | 0.141 | Cell wall synthesis inhibitor | 0.141 0.074 DBMET00909 | DBMET00909 | |
| 0.038 | 0.087 | 0.058 | Carbonic anhydrase stimulant | 0.058 0.042 DBMET00909 | DBMET00909 | |
| 0.08 | 0.13 | 0.103 | Microtubule formation inhibitor | 0.103 0.086 DBMET00909 | DBMET00909 | |
| 0.096 | 0.149 | 0.124 | Neurotrophic factor | 0.124 0.089 DBMET00909 | DBMET00909 | |
| 0.024 | 0.077 | 0.039 | Membrane dipeptidase inhibitor | 0.039 0.029 DBMET00909 | DBMET00909 | |
| 0.073 | 0.131 | 0.098 | Mucolytic | 0.098 0.08 DBMET00909 | DBMET00909 | |
| 0.167 | 0.225 | 0.24 | Antithrombotic | 0.24 0.134 DBMET00909 | DBMET00909 | |
| 0.029 | 0.098 | 0.088 | Beta 1 adrenoreceptor antagonist | 0.088 0.014 DBMET00909 | DBMET00909 | |
| 0.028 | 0.1 | 0.051 | Potassium channel (Inward rectifier) blocker | 0.051 0.032 DBMET00909 | DBMET00909 | |
| 0.112 | 0.187 | 0.166 | Insulin sensitizer | 0.166 0.112 DBMET00909 | DBMET00909 | |
| 0.025 | 0.11 | 0.075 | Beta 2 adrenoreceptor antagonist | 0.075 0.014 DBMET00909 | DBMET00909 | |
| 0.027 | 0.127 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.044 DBMET00909 | DBMET00909 | |
| 0.033 | 0.141 | 0.05 | Glucosylceramidase inhibitor | 0.05 0.049 DBMET00909 | DBMET00909 | |
| 0.032 | 0.156 | 0.087 | Beta adrenoreceptor antagonist | 0.087 0.023 DBMET00909 | DBMET00909 | |
| 0.065 | 0.202 | 0.13 | Electron transport complex I inhibitor | 0.13 0.035 DBMET00909 | DBMET00909 | |
| 0.027 | 0.17 | 0.049 | Beta adrenoreceptor agonist | 0.049 0.019 DBMET00909 | DBMET00909 | |
| 0.089 | 0.252 | 0.159 | Spasmolytic | 0.159 0.155 DBMET00909 | DBMET00909 | |
| 0.038 | 0.212 | 0.15 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.15 0.047 DBMET00909 | DBMET00909 | |
| 0.037 | 0.211 | 0.15 | Abl kinase inhibitor | 0.15 0.047 DBMET00909 | DBMET00909 | |
| 0.034 | 0.208 | 0.067 | Beta 3 adrenoreceptor antagonist | 0.067 0.038 DBMET00909 | DBMET00909 | |
| 0.128 | 0.313 | 0.265 | Sodium/bile acid cotransporter inhibitor | 0.265 0.113 DBMET00909 | DBMET00909 | |
| 0.073 | 0.267 | 0.175 | Interleukin agonist | 0.175 0.144 DBMET00909 | DBMET00909 | |
| 0.059 | 0.253 | 0.111 | Interleukin 4 antagonist | 0.111 0.099 DBMET00909 | DBMET00909 | |
| 0.036 | 0.232 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.04 DBMET00909 | DBMET00909 | |
| 0.03 | 0.242 | 0.119 | Adrenaline agonist | 0.119 0.026 DBMET00909 | DBMET00909 | |
| 0.039 | 0.414 | 0.31 | Interleukin antagonist | 0.31 0.046 DBMET00909 | DBMET00909 | |
| 0.021 | 0.437 | 0.08 | Somatostatin 1 agonist | 0.08 0.052 DBMET00909 | DBMET00909 | |
| 0.031 | 0.548 | 0.162 | Tumour necrosis factor alpha release inhibitor | 0.162 0.142 DBMET00909 | DBMET00909 | |
| 0.099 | 0.625 | 0.44 | Calcium channel L-type activator | 0.44 0.056 DBMET00909 | DBMET00909 | |
| 0.077 | 0.631 | 0.24 | Peptidyltransferase inhibitor | 0.24 0.058 DBMET00909 | DBMET00909 | |
| 0.009 | 0.63 | 0.264 | Bronchodilator | 0.264 0.012 DBMET00909 | DBMET00909 | |
| 0.028 | 0.778 | 0.658 | Antiinflammatory | 0.658 0.039 DBMET00909 | DBMET00909 | |
| 0.048 | 0.842 | 0.206 | Interleukin 2 agonist | 0.206 0.178 DBMET00909 | DBMET00909 | |
| 0.004 | 0.905 | 0.105 | Adrenaline antagonist | 0.105 0.051 DBMET00909 | DBMET00909 | |
| 0.004 | 0.907 | 0.107 | Antiadrenergic | 0.107 0.052 DBMET00909 | DBMET00909 | |
| 0.005 | 0.937 | 0.476 | Cardiotonic | 0.476 0.018 DBMET00909 | DBMET00909 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |